Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.
暂无分享,去创建一个
Serum aluminium concentrations and biopsy specimens of bone were examined in 56 patients with end stage chronic renal failure receiving maintenance haemodialysis. Deposits of aluminium in bone specimens were often associated with low bone formation with or without osteomalacia. Serum aluminium concentrations of greater than 3.7 mumol/l (10 micrograms/100 ml) indicated a high probability of deposits of aluminium in bone specimens, although high serum concentrations did not predict the type of renal bone disease. Biopsy of the bone is the best method of detecting aluminium intoxication of bone. A serum aluminium concentration of 3.7 mumol/l should be the threshold beyond which bone biopsy should be performed to confirm an overload of aluminium and identify histological bone changes induced by aluminium.
[1] Y. Berland,et al. Predictive value of desferrioxamine infusion test for bone aluminium deposits in hemodialyzed patients. , 1985, Nephron.
[2] M. Chapuy,et al. [Aluminum poisoning in renal dialysis patients: bone histology. Value of quantitative bone biopsy]. , 1984, Presse medicale.
[3] D. Massart,et al. SERUM ALUMINIUM MEASUREMENTS IN RENAL BONE DISEASE , 1983, The Lancet.
[4] F. Fagioli,et al. IS SERUM ALUMINIUM MONITORING USEFUL IN EVALUATING ALUMINIUM INTOXICATION? , 1983, The Lancet.